This website uses cookies to provide users with the best experience possible. For more information, please read our Terms of Use. By clicking "Accept and hide this message", you agree to the Terms of Use and the use of cookies.

Contact us now

Lab Science, Pharmaceuticals & Biotechnology

Diagnosis: Personalized medicine
and digitalization

The lab science, pharmaceutical and biotechnology sectors are no longer isolated. They have moved closer together thanks to personalized medicine, individual diagnostics and digital networks. Complex – often even cross-sector – development projects will have to be managed in order to explore new (growth) markets with cost-efficient treatments.

Healthy innovation

Personalized medicine is a big trend, supported by advances in diagnostics and a better understanding of medical conditions.

This creates innovation opportunities for the lab science, pharmaceutical and biotechnology sectors. The challenge: A shorter time to market and lower production costs compete with a rising product complexity. Possible areas of action are:

Diagnostics: High-throughput in the central lab vs. compact individual solutions at the point of care